| Product Code: ETC9972892 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market - Industry Life Cycle |
3.4 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market - Porter's Five Forces |
3.5 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among healthcare professionals about paroxysmal nocturnal hemoglobinuria (PNH) and its diagnosis and treatment |
4.2.2 Growing prevalence of PNH in the United States |
4.2.3 Advancements in medical technology leading to improved diagnosis and treatment options for PNH patients |
4.3 Market Restraints |
4.3.1 High cost associated with PNH treatment and management |
4.3.2 Limited availability of specialized healthcare professionals with expertise in managing PNH patients |
4.3.3 Stringent regulatory requirements for approval of new PNH therapies |
5 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Trends |
6 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market, By Types |
6.1 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Revenues & Volume, By Medication, 2021- 2031F |
6.1.4 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Revenues & Volume, By Supplements, 2021- 2031F |
6.1.5 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Revenues & Volume, By Blood Transfusion, 2021- 2031F |
6.1.6 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Revenues & Volume, By Bone Marrow Transplant, 2021- 2031F |
6.1.7 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Revenues & Volume, By Immunosuppressive Therapy, 2021- 2031F |
6.2 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market, By End-user |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.2.3 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.2.4 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Import-Export Trade Statistics |
7.1 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Export to Major Countries |
7.2 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Imports from Major Countries |
8 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Key Performance Indicators |
8.1 Average time to diagnosis of PNH patients |
8.2 Patient adherence to prescribed PNH treatment regimens |
8.3 Number of clinical trials focused on developing innovative therapies for PNH |
8.4 Patient satisfaction with PNH treatment outcomes |
8.5 Rate of hospital readmissions among PNH patients |
9 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market - Opportunity Assessment |
9.1 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market - Competitive Landscape |
10.1 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Paroxysmal Nocturnal Hemoglobinuria Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here